Related Experiment Videos

Use of magnesium sulfate for pediatric patients with acute asthma exacerbations

Pamela J Kelley1, Traci D Arney

  • 1Emergency Department, Banner Children's Hospital, Banner Desert Medical Center, Mesa, AZ, USA.

Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
|October 6, 2005
PubMed

Insights

Pediatric asthma is a growing concern, impacting many children. Early diagnosis and management are key to reducing childhood asthma deaths and improving outcomes.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Allergy and Immunology

Background:

  • Asthma is the most common chronic pediatric disease, with increasing prevalence.
  • Childhood asthma mortality remains a significant public health issue.
  • Effective diagnosis, education, and management are crucial for reducing pediatric asthma morbidity and mortality.

Purpose of the Study:

  • To discuss the prevalence, pathophysiology, diagnosis, and treatment of pediatric asthma.
  • To highlight the importance of early assessment and appropriate interventions.
  • To explore the role of magnesium sulfate in managing acute asthma exacerbations.

Main Methods:

  • Review of current literature on pediatric asthma.
  • Discussion of diagnostic tools including medical history, physical examination, pulmonary function tests, and pediatric asthma scores.
  • Analysis of treatment strategies for acute asthma exacerbations.

Main Results:

  • Asthma diagnosis relies on comprehensive history, physical exam, and objective measures like PFTs.
  • Standard treatment for acute exacerbations involves bronchodilators and corticosteroids.
  • Magnesium sulfate is presented as a potential adjunctive therapy for severe exacerbations.

Conclusions:

  • Prompt diagnosis and management are vital for positive pediatric asthma outcomes.
  • Current treatment guidelines are effective but may require augmentation for severe cases.
  • Further research into therapies like magnesium sulfate may improve management of severe pediatric asthma exacerbations.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...